GESTIÓN EN SALUD PÚBLICA: AHRQ Patient Safety Network ► Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

domingo, 10 de mayo de 2015

AHRQ Patient Safety Network ► Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

AHRQ Patient Safety Network

PSNet header image

Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Diabetes Care. 2015;38:716-722.

Insulin is a high-alert medication that can lead to harm if incorrectly administered. Insulin pump problemscan be caused by human, mechanical, or drug stability failures. This policy statement describes ways to useadverse event data, manufacturer information, and technical specifications to enhance the safety of insulin therapy.

PubMed citation